Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02072603 · ClinicalTrials.gov registry record · NA

Evaluation of the HITSystem to Improve Early Infant Diagnosis Outcomes in Kenya

A NA study of HIV, sponsored by Sarah Kessler, PhD, MPH.

Completed
Registry status
NA
Development phase
1,815
Enrollment target
2
Study locations

NCT02072603 is a NA study of HIV that has completed, run by Sarah Kessler, PhD, MPH. The registered enrollment target is 1,815 participants, above the 434-participant average among 303 other HIV trials with a reported enrollment target (318% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02072603, a NA study of HIV, has completed, sponsored by Sarah Kessler, PhD, MPH.

COMPLETED
Registry status
NA
Development phase
1,815 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine the effectiveness of the HITSystem in maximizing early infant diagnosis (EID) service utilization for HIV-exposed infants and early antiretroviral therapy (ART) initiation for infants diagnosed with HIV.

Conditions Studied

Interventions

  • OTHER Standard of Care
  • OTHER HITSystem

Study Locations (2)

Kansas

  • University of Kansas Medical Center - Kansas City

Other

  • Kenyan Medical Research Institute - Nairobi

Trial Details

FieldValue
Enrollment Target 1,815 participants
Start Date 2014-03-30
Est. Completion 2020-04-30
Phase NA

Sponsor

Sarah Kessler, PhD, MPH

1 total trials

What the Registry Record Tells You About NCT02072603

The ClinicalTrials.gov registry entry for NCT02072603 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,815 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 434-participant average among 303 other HIV trials with a reported enrollment target (318% higher). The listed sponsor is Sarah Kessler, PhD, MPH, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT02072603 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kansas, Other.

Frequently Asked Questions

What is clinical trial NCT02072603 about?

NCT02072603 is a clinical study titled "Evaluation of the HITSystem to Improve Early Infant Diagnosis Outcomes in Kenya". The purpose of this study is to determine the effectiveness of the HITSystem in maximizing early infant diagnosis (EID) service utilization for HIV-exposed infants and early antiretroviral therapy (ART) initiation for infants diagnosed with HIV.

What is the current status of trial NCT02072603?

This trial is currently completed. It is a NA study. The enrollment target is 1,815 participants. The study started on 2014-03-30. Estimated completion is 2020-04-30.

What conditions does trial NCT02072603 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT02072603?

The interventions under investigation include: Standard of Care (OTHER), HITSystem (OTHER).

Who is sponsoring clinical trial NCT02072603?

This trial is sponsored by Sarah Kessler, PhD, MPH, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02072603 being conducted?

This trial has 2 study locations across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.